Home > Boards > US OTC > Medical - Equipment > PCT Ltd. (PCTL)

$PCTL MUST READ. REGARDING - (IEVM) Integrated Environmental

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
MattDuke Member Profile
 
Followed By 9
Posts 742
Boards Moderated 0
Alias Born 03/21/19
160x600 placeholder
MattDuke   Wednesday, 09/11/19 04:58:27 AM
Re: GoldiS post# 27149
Post # of 28700 
$PCTL MUST READ. REGARDING - (IEVM) Integrated Environmental Technologies, Ltd. Intellectual Property AND DD OF WHOLE MARKET MARKET SEGMENT.
PCTL has had thier Excelyte®, which was THEIR CLAIM TO FAME, They paid 125,000 for thier Intellectual Propety in 2017 and took their workers. AS YOU CAN SEE BELOW ALL IN THIER 2018 FORM 10-K PLUS ALL THE OTHER INTELLECTUAL PROPERTY AND PATENTS THEY NOW OWN THE RIGHTS TO.

On March 13, 2017, the Company entered into a Registration Transfer Agreement (“Transfer Agreement”) and a Data License and Assignment Agreement (“Data Agreement”) with a third party. Pursuant to the Transfer Agreement, the Company received United States Environmental Protection Agency’s (“EPA”) Registration number 82341-4 for Excelyte® VET for a one-time fee of $125,000.

Intellectual Property

EPA product registrations of disinfectants and pesticides allow the registered products to be sold and distributed with labels identifying specific laboratory tested and proven kill claims of its effectiveness against specific microbial pathogens. Below is a summary of recent EPA registrations, EPA sub-registrations and other intellectual property the Company has acquired. The Company continues to hold certain intellectual properties relative to the Soloplax biodegradable plastics technology but does not anticipate pursuing commercialization of the technology associated in the foreseeable future.

On December 15, 2016, Paradigm acquired an EPA sub-registration (#82341-1-92108), which provides for entry into the facilities and agricultural markets described previously in this document. The company is actively pursuing sales under this registration and label. In addition, the Company has registered its products in several states, under its US EPA No. 92108-1.

On March 13, 2017, the Company entered into a Registration Transfer Agreement (“Transfer Agreement”) and a Data License and Assignment Agreement (“Data Agreement”) with a third party. Pursuant to the Transfer Agreement, the Company received United States Environmental Protection Agency’s (“EPA”) Registration number 82341-4 for Excelyte® VET for a one-time fee of $125,000.

On April 6, 2017, Paradigm, acquired the complete intellectual property, including know-how, trade secrets and patent rights to the hardware, firmware and software comprising the product inventory generation, disbursement, containerization, tracking and reporting system, trademarked as the Annihilyzer ® System. The Annihilyzer® System is designed to be employed on-site in healthcare facilities. The company already owns IP rights in the generation system employed in this integrated technology system.

Paradigm has developed proprietary know-how related to the reactor cells and generation systems that generate our Hydrolyte ® and Catholyte products. Paradigm continues, through its research and development program, to perfect the production innovation, know-how, trade secrets and patentable innovations incorporated into the improved production, inventory management and reporting systems. Current focus is on customizing system and equipment design to suite the production parameters and conditions in various specific venues and applications, e.g., agricultural field setting vs. packing house or oil and gas field.

On April 12, 2018 the Company entered into a Purchase Agreement with a third party to purchase its exclusive rights to US EPA Product Registration No 83241-1 for a fixed fee. The Company paid $5,000 on execution of the agreement and has continued to make periodic installment payments for the purchase of this Registration. At December 31,2018, the Company owed $45,000 of installment payments.


ALSO WHAT THE INTELLECTUAL DISHONEST PEOPLE ON THIS BOARD ARE NOT TELLING THE PEOPLE WHO ARE TRYING TO REAL DD INCLUDING MYSELF ARE JUST TRYING TO CREATE DOUBT.
WHICH I HAVE ABSOLUTELY NONE NOW BECAUSE OF

1. SHARE STRUCTURE
2. EVERYTHING POINTS TO DEAL DONE.
3. I MYSELF HAVE SPOKEN TO THE HEAD OF TIPS, HEAD OF NYP CHILDREN HOSPITAL EVS DEPARTMENT, ACE SUPPLY AND MULTIPLE PEOPLE WHO KNOW HOW BIG THIS PRODUCT WILL BE.
4. IF DEAL IS NOT DONE, THEY OWN THIS INDUSTRY AGAIN AS SHOWN IN THE 2018 10K , THEY OWN THIS BILLION DOLLAR INDUSTRY BECAUSE THEY BOUGHT ALL PROPERTY AND PATENTED THE REST TO BE THE ONLY NON TOXIC 99.999999 PERCENT DISINFECTANT OF ALL MAJOR INFECTIOUS DISEASES.
AND YES THEY WENT INTO DEBT DOING IT, BUT GUESS WHAT IT IS LESS THEN TEN PERCENT OF THE MULTI BILLION DOLLAR MARKET THEY ARE ENTERING AS THE NUMBER 1 NON TOXIC COMPANY , WHICH IS THE FUTURE.

SEE BELOW ALL IN THIER 2018 FORM 10-K

Competition

In all our target markets, Paradigm will compete directly with large firms selling competing, but toxic, legacy cleanser and disinfectant products that are manufactured off-site and shipped to customers or distributors. These competitors have longer operating histories, more experience, substantially greater financial and human resources, greater size, more substantial research and development and marketing operations, established distribution channels and are well positioned in the market to fight aggressively to defend their market share. However, the combined markets in which Paradigm is engaged are so massive that its competitive position as non-toxic and, in a significant number of applications, less expensive should allow Paradigm to prosper. Paradigm’s on-site generation technology and Patented RFID Tracking and Reporting System provides a substantial competitive advantage in addition to its non-toxic properties.

There are a limited number of potential competitors providing some form of anolyte-based biocide. Based on management’s research these companies are largely in early operating stages, concentrated in local or regional markets and have no advanced technology or pricing advantage. These include Aquaox, Ecologic Solutions, and MIOX Corporation.

In the institutional facilities and agricultural industries, Paradigm believes that its proprietary integrated technologies solutions in production, distribution, applications management and tracking should provide a competitive advantage in direct competition. In the oil and gas industry Paradigm has demonstrated the effectiveness and efficiencies of its products and processes and commercial acceptance from its customers. It is well positioned with respect to other companies providing anolyte-based biocides.

THIER COMPETITORS IF YOU CALL THIS COMPETING. LMAO

Aquaox - https://www.aquaox.com/sustainable-cleaning-disinfecting-sanitizing-products/solutions/

Ecologic Solutions - http://www.ecologicsolutions.com/industries/products/#all/1/list

MIOX Corporation - https://www.miox.com/products/on-site-generation/

1 YEAR, 5, 10 YEARS DOWN THE ROAD WHEN THIS IS THE NEXT BLEACH OF NON TOXIC CHEMICALS. YOU WILL BE TELLING YOU KIDS HOW YOU MADE YOUR FORTUNE OR WHAT COULD OF BEEN. GOD BLESS EVERYONE.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist